Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$1.08 - $1.83 $730 - $1,237
676 Added 0.89%
76,717 $87,000
Q2 2022

Aug 11, 2022

SELL
$1.3 - $2.49 $46,243 - $88,574
-35,572 Reduced 31.87%
76,041 $112,000
Q4 2021

Feb 11, 2022

SELL
$2.72 - $5.72 $780 - $1,641
-287 Reduced 0.26%
111,613 $307,000
Q3 2021

Nov 12, 2021

BUY
$4.83 - $7.2 $540,477 - $805,680
111,900 New
111,900 $671,000

Others Institutions Holding CLSD

About Clearside Biomedical, Inc.


  • Ticker CLSD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,190,700
  • Market Cap $61.4M
  • Description
  • Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...
More about CLSD
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.